Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (101-110 of 308) with videos related to

Pageof 31
Sort By:
Cancer|June 28, 2012
Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemiaJonathan How, Jenna Sykes, Vikas Gupta, et al.
Oncotarget|September 8, 2016
Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutationsJean-François Spinella, Pauline Cassart, Chantal Richer, et al.
Leukemia Research|May 31, 2022
NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1Davidson Zhao, Mojgan Zarif, Entsar Eladl, et al.
Leukemia|November 16, 2019
Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AMLZhuo Ren, Mariusz Shrestha, Takashi Sakamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2013
A pilot phase II RCT of a home-based exercise intervention for survivors of AMLShabbir M H Alibhai, Sara O'Neill, Karla Fisher-Schlombs, et al.
Haematologica|February 15, 2020
SIRPαFc treatment targets human acute myeloid leukemia stem cellsOleksandr Galkin, Jessica McLeod, James A Kennedy, et al.
Hematological Oncology|September 7, 2016
Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysisUday Deotare, Marwan Shaheen, Joseph M Brandwein, et al.
Leukemia & Lymphoma|May 27, 2004
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapyVikas Gupta, Qi-Long Yib, Joseph Brandwein, et al.
Redox Biology|March 19, 2022
PRMT5 regulates ATF4 transcript splicing and oxidative stress responseMagdalena M Szewczyk, Genna M Luciani, Victoria Vu, et al.
Leukemia Research|September 10, 2023
AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blastsDavidson Zhao, Qianghua Zhou, Mojgan Zarif, et al.
Pageof 31

Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
Cancer|June 28, 2012
Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemiaJonathan How, Jenna Sykes, Vikas Gupta, et al.
Oncotarget|September 8, 2016
Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutationsJean-François Spinella, Pauline Cassart, Chantal Richer, et al.
Leukemia Research|May 31, 2022
NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1Davidson Zhao, Mojgan Zarif, Entsar Eladl, et al.
Leukemia|November 16, 2019
Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AMLZhuo Ren, Mariusz Shrestha, Takashi Sakamoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2013
A pilot phase II RCT of a home-based exercise intervention for survivors of AMLShabbir M H Alibhai, Sara O'Neill, Karla Fisher-Schlombs, et al.
Haematologica|February 15, 2020
SIRPαFc treatment targets human acute myeloid leukemia stem cellsOleksandr Galkin, Jessica McLeod, James A Kennedy, et al.
Hematological Oncology|September 7, 2016
Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysisUday Deotare, Marwan Shaheen, Joseph M Brandwein, et al.
Leukemia & Lymphoma|May 27, 2004
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapyVikas Gupta, Qi-Long Yib, Joseph Brandwein, et al.
Redox Biology|March 19, 2022
PRMT5 regulates ATF4 transcript splicing and oxidative stress responseMagdalena M Szewczyk, Genna M Luciani, Victoria Vu, et al.
Leukemia Research|September 10, 2023
AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blastsDavidson Zhao, Qianghua Zhou, Mojgan Zarif, et al.
Pageof 31